664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Outcomes - Alexander, Elizabeth; Schranz, Jennifer; Das, Anita F; Moran, Gregory J; Sandrock, Christian; File, Thomas M; Gelone, Steven P (Open Forum Infectious Diseases, 2019)